Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing Pharmaceutical Technology
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing - DCAT Value Chain Insights
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing DCAT Value Chain Insights